<DOC>
	<DOCNO>NCT01512381</DOCNO>
	<brief_summary>The purpose study determine whether cardiac resynchronization therapy ( CRT ) superior interventricular right ventricle ( RV ) septal pace respect reverse remodeling ( LV ESD ) morbidity patient less preserved ( less 45 % ) ejection fraction ( EF ) , persistent/permanent atrial fibrillation ( AF ) successfully receive atrioventricular ( AV ) junction ablation ablation ( 100 % pacemaker dependency )</brief_summary>
	<brief_title>Atrioventricular Node Ablation Patients With Atrial Fibrillation Moderate Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Age 1875 year CHF IIIII NYHA Persistent/permanent AF require AV node ablation LVEF &lt; 45 % Signed informed consent Able complete testing require clinical protocol Myocardial infarction stroke less 3 month prior randomization Patients require revascularization , radiofrequency ablation pulmonary vein substrate AF The congenital acquire heart disease , LV aneurysm , require surgical correction Active inflammatory autoimmune diseases myocardium The thyrotoxicosis The disease limit life expectancy ( cancer , tuberculosis , etc . ) Contraindications anticoagulant administration CHADS2 &gt; 2 Uncompliant patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>heart failure</keyword>
	<keyword>CRT</keyword>
	<keyword>atrial fibrillation</keyword>
	<keyword>AV junction ablation</keyword>
</DOC>